March 17, 2023 02:14 PM EDT
FDA+

GAO on com­bo prod­uct patents: Stake­hold­ers split on need for Or­ange Book tweaks

Zachary Brennan

Senior Editor

The Gov­ern­ment Ac­count­abil­i­ty Of­fice (GAO) late Thurs­day re­leased a re­port eval­u­at­ing whether Or­ange Book patent list­ings re­lat­ed to drug-de­vice com­bi­na­tion prod­ucts …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times